Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

Treatment Options for Hypercholesterolemia and Combined Dyslipidemia: Focus on Pitavastatin

Submit a Paper


Clinical Medicine Reviews in Therapeutics 2011:3 311-324

Review

Published on 14 Sep 2011

DOI: 10.4137/CMRT.S7488


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Therapeutics

Abstract

The progression of atherosclerosis and thus risk of cardiovascular disease is influenced by a variety of risk factors, including high levels of low-density lipoprotein cholesterol (LDL-C) and low levels of high-density lipoprotein cholesterol (HDL-C). Lowering the serum cholesterol level with diet or drug therapy slows the progression of angiographically documented coronary atherosclerosis in patients with arterial bypass grafts. Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, are the most potent pharmacologic agents for lowering total cholesterol (TC) and LDL-C.

We conducted a review analyzing clinical efficacy and safety of pitavastatin, the latest statin to be commercialized, including the most important studies about pitavastatin published in the last ten years. Pitavastatin proved to be as effective as atorvastatin, and a little inferior to rosuvastatin in improving lipid profile, it also proved to be safe and well tolerated. Because of its positive pleiotropic effects on coronary plaque volume and fibro-fatty composition, pitavastatin could be a valid option for the treatment of hypercholesterolemia and combined dyslipidemia.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)


Sharing


What Your Colleagues Say About Libertas Academica
testimonial_image
I am highly impressed with the professional integrity, efficiency, and friendly communication of the editorial staff at Libertas Academia.  Recently, I had an authorship issue which I brought to the attention of the Publisher and CEO (Mr. Tom Hill) of the journal Air, Soil, and Water Research.  The issue was taken very seriously and was handled appropriately in an efficient and timely manner.  I would like to express my sincere appreciation and utmost  respect  for ...
Dr Mustafa Selim (Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube